C62.10
Malignant neoplasm of unspecified descended testis
Clinical Classification Guidelines
Medical Intelligence & Overview
Malignant neoplasm of an unspecified descended testis refers to a cancerous growth found in the testis that has not been specifically located within the descended portion of the testicle. The testis, or testicle, is an essential part of the male reproductive system, responsible for producing sperm and testosterone. When cancer develops in this organ, it can affect the patient's health significantly. This condition is classified under ICD-10 code C62.10, emphasizing the importance of accurate diagnosis and understanding of the disease for effective management and treatment.
Causes & Symptoms
Clinical Causes: Genetic factors and family history of testicular cancer Undescended testicle (cryptorchidism), which increases the risk History of testicular cancer in the other testis Certain genetic syndromes such as Klinefelter syndrome Exposure to environmental chemicals or toxins Personal history of HIV infection or other immune deficiencies
Key Symptoms: A painless lump or swelling in the testicle A feeling of heaviness or discomfort in the scrotum Dull ache in the lower abdomen or groin An enlargement or change in size of the testis Rarely, sudden collection of fluid in the scrotum
Diagnostic & Treatment
Diagnosis Path: Diagnosing malignant neoplasm of the descended testis involves several steps to confirm the presence of cancer and determine its extent. Healthcare providers typically use the following methods: - **Physical Examination:** Inspection and palpation of the testicles and surrounding tissues. - **Ultrasound Imaging:** To assess the size, shape, and internal characteristics of the testis and detect any abnormal masses. - **Blood Tests:** Checking for tumor markers such as alpha-fetoprotein (AFP), human chorionic gonadotropin (HCG), and lactate dehydrogenase (LDH). - **Imaging Scans:** CT scans, MRI, or chest X-rays may be used to evaluate the spread of the cancer. - **Biopsy:** Often not performed pre-surgery; instead, tissue is examined after surgical removal of the testis (orchiectomy).
Treatment Protocols: Treatment options depend on the stage of the tumor, the patient's overall health, and preferences. Common approaches include: - **Surgical Removal:** Orchiectomy, which involves removing the affected testis. - **Chemotherapy:** Uses drugs to target and destroy cancer cells; often administered after surgery if cancer has spread. - **Radiation Therapy:** Less commonly used but can be an option for certain types of testicular cancer. - **Surveillance:** Regular follow-up exams, imaging, and blood tests to monitor for recurrence, particularly in early-stage cases. Multidisciplinary care involving urologists, oncologists, and radiologists is essential for optimal outcomes. Early detection and treatment are crucial for improving prognosis.
Clinical Advice & FAQs
Billing Guidance
Is C62.10 a billable ICD-10 code?
Yes, C62.10 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report C62.10?
Clinical documentation must specify the nature of Malignant neoplasm of unspecified descended testis and any associated comorbidities for accurate reporting.
Cite this Clinical Reference
